XML 73 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Parent Company Only)
Schedule I — Condensed Financial Information of Registrant
Condensed Statements of Operations
(Parent Company Only)
Years Ended December 31,
2023
2022(1)
2021(1)
(in millions)
Revenues
Net investment income$77 $16 $27 
Other revenues5 6 9 
Total revenues82 22 36 
Banking and deposit interest expense35 8 2 
Total net revenues47 14 34 
Expenses
Distribution expenses46 4 7 
Interest and debt expense138 104 102 
General and administrative expense306 265 258 
Total expenses490 373 367 
Pretax loss before equity in earnings of subsidiaries(443)(359)(333)
Income tax provision
142 139 157 
Loss before equity in earnings of subsidiaries(585)(498)(490)
Equity in earnings of subsidiaries, net of tax
3,141 3,647 3,907 
Net income2,556 3,149 3,417 
Other comprehensive income (loss), net of tax780 (1,904)(498)
Total comprehensive income (loss)
$3,336 $1,245 $2,919 
(1) Certain prior period amounts have been restated. See Note 1 for more information.
See Notes to Condensed Financial Information of Registrant.
Schedule I — Condensed Financial Information of Registrant
Condensed Balance Sheets
(Parent Company Only)
December 31,
2023
2022(1)
(in millions, except share amounts)
Assets
Cash and cash equivalents$519 $361 
Investments841 831 
Loans to subsidiaries489 249 
Due from subsidiaries
246 338 
Receivables49 26 
Land, buildings, equipment, and software, net of accumulated depreciation of $791 and $874, respectively
265 216 
Investments in subsidiaries6,974 5,843 
Other assets1,580 1,262 
Total assets$10,963 $9,126 
Liabilities and Equity
Liabilities:
Accounts payable and accrued expenses$1,229 $999 
Due to subsidiaries347 107 
Borrowings from subsidiaries580 602 
Long-term debt3,398 2,819 
Other liabilities680 796 
Total liabilities6,234 5,323 
Equity:
Common shares ($0.01 par value; shares authorized, 1,250,000,000; shares issued, 336,780,893 and 335,864,062, respectively)
3 3 
Additional paid-in capital9,824 9,517 
Retained earnings21,905 19,918 
Treasury shares, at cost (236,607,681 and 230,585,072 shares, respectively)
(25,237)(23,089)
Accumulated other comprehensive income (loss), net of tax, including amounts applicable to equity investments in subsidiaries(1,766)(2,546)
Total equity4,729 3,803 
Total liabilities and equity$10,963 $9,126 
(1) Certain prior period amounts have been restated. See Note 1 for more information.
See Notes to Condensed Financial Information of Registrant.
Schedule I — Condensed Financial Information of Registrant
Condensed Statements of Cash Flows
(Parent Company Only)
Years Ended December 31,
2023
2022(1)
2021(1)
(in millions)
Cash Flows from Operating Activities
Net income$2,556 $3,149 $3,417 
Equity in earnings of subsidiaries(3,141)(3,647)(3,907)
Dividends received from subsidiaries3,025 2,512 4,027 
Other operating activities, primarily with subsidiaries453 226 343 
Net cash provided by (used in) operating activities
2,893 2,240 3,880 
Cash Flows from Investing Activities
Available-for-Sale securities:
Proceeds from sales4 — — 
Maturities, sinking fund payments and calls43 153 93 
Purchases(38)(124)(82)
Proceeds from sales of other investments
— 7 1 
Purchase of other investments(10)(1)(16)
Proceeds from sales of land, buildings, equipment and software
— — 1 
Purchase of land, buildings, equipment and software(87)(70)(28)
Contributions to subsidiaries(324)(743)(1,291)
Return of capital from subsidiaries— 207 39 
Repayment of loans to subsidiaries
1,992 1,960 2,701 
Issuance of loans to subsidiaries(2,232)(1,726)(2,937)
Other, net2 — — 
Net cash provided by (used in) investing activities
(650)(337)(1,519)
Cash Flows from Financing Activities
Dividends paid to shareholders(550)(534)(511)
Repurchase of common shares(2,127)(1,978)(2,030)
Issuance of long-term debt, net of issuance costs
1,335 495 4 
Repayments of long-term debt(760)(510)(9)
Borrowings from subsidiaries1,003 1,210 244 
Repayments of borrowings from subsidiaries(951)(1,034)(403)
Exercise of stock options— — 1 
Other, net(35)(18)99 
Net cash provided by (used in) financing activities
(2,085)(2,369)(2,605)
Net increase (decrease) in cash and cash equivalents158 (466)(244)
Cash and cash equivalents at beginning of period
361 827 1,071 
Cash and cash equivalents at end of period
$519 $361 $827 
Supplemental Disclosures:
Interest paid on debt$129 $98 $95 
Income taxes paid, net
233 91 173 
Non-cash dividends from subsidiaries77 — — 
Non-cash contributions to subsidiaries
— — 52 
(1) Certain prior period amounts have been restated. See Note 1 for more information.
See Notes to Condensed Financial Information of Registrant.
Schedule I — Condensed Financial Information of Registrant
Notes to Condensed Financial Information of Registrant
(Parent Company Only)
1. Basis of Presentation
The accompanying Condensed Financial Statements include the accounts of Ameriprise Financial, Inc. (the “Parent Company”) and, on an equity basis, its subsidiaries and affiliates. The Condensed Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles. The financial information of the Parent Company should be read in conjunction with the Consolidated Financial Statements and Notes of Ameriprise Financial, Inc. and its subsidiaries (“Ameriprise Financial”). Parent Company revenues and expenses, other than interest and debt expense, are primarily related to intercompany transactions with subsidiaries and affiliates.
In August 2018, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) related to long-duration insurance contracts (ASU 2018-12). When our insurance subsidiaries adopted the standard effective January 1, 2023 with a transition date of January 1, 2021 (the “transition date”), opening equity was adjusted for the adoption impacts to retained earnings and accumulated other comprehensive income (loss) (“AOCI”) and prior periods were restated. The adoption impact as of January 1, 2021 was a reduction in total equity of $1.9 billion, of which $0.9 billion and $1.0 billion were reflected in retained earnings and AOCI, respectively.
2. Investments
On December 23, 2020, RiverSource Life Insurance Company (“RiverSource Life”) issued a $500 million unsecured 3.5% surplus note due December 31, 2050 to the Parent Company. The surplus note is subordinate in right of payment to the prior payment in full of RiverSource Life’s obligations to policyholders, claimants and beneficiaries and all other creditors. No payment of principal or interest shall be made without the prior approval of the Minnesota Department of Commerce and such payments shall be made only from RiverSource Life’s statutory surplus. Interest payments, which commenced on June 30, 2021, are due semi-annually in arrears on June 30 and December 31. Subject to the preceding conditions, RiverSource Life may prepay all or a portion of the principal at any time. The held-to-maturity investment was $500 million as of both December 31, 2023 and 2022 and is recorded in Investments on the Parent Company’s Condensed Balance Sheets. For the years ended December 31, 2023, 2022 and 2021, interest income was $18 million, $18 million and $17 million, respectively, and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.
The Parent Company invested in the residual tranche of an asset backed security structure issued by Ameriprise Advisor Financing, LLC (“AAF”) and in the residual tranche of an asset backed security structure issued by Ameriprise Advisor Financing 2, LLC (“AAF 2”), both subsidiaries of the Parent Company. The asset backed securities are collateralized by a portfolio of loans issued to advisors affiliated with Ameriprise Financial Services, LLC (“AFS”), a subsidiary of the Parent Company. During the third quarter of 2022, the Parent Company redeemed the outstanding residual tranche issued by AAF, realizing a $23 million loss, and invested $30 million in a new residual tranche issued by AAF 2. As of December 31, 2023 and 2022, the fair value of the residual tranche issued by AAF 2 was $30 million and $27 million, respectively. The fair value of the residual tranche is reported in Investments on the Parent Company’s Condensed Balance Sheets. For each of the years ended December 31, 2023, 2022 and 2021, interest income was $7 million and is reported in Net investment income on the Parent Company’s Condensed Statements of Operations.
3. Debt
All of the debt of Ameriprise Financial is borrowings of the Parent Company, except as indicated below.
•As of both December 31, 2023 and 2022, Ameriprise Financial had $201 million of borrowings from the Federal Home Loan Bank of Des Moines, which is collateralized with commercial mortgage backed securities.
•As of December 31, 2023 and 2022, Ameriprise Financial debt included $1 million and $2 million, respectively, of other subsidiary lease obligations.
4. Borrowings from Subsidiaries
The Parent Company has intercompany lending arrangements with its subsidiaries. At the end of each business day, taking into consideration all legal and regulatory requirements associated with its subsidiaries, the Parent Company is entitled to draw on all funds in specified bank accounts. Repayment of all or a portion of the funds is due on demand. As of December 31, 2023 and 2022, the Company had $375 million and $411 million, respectively, available for repayment due on demand. The Parent Company also has revolving credit agreements with its subsidiaries as the borrower aggregating $1.3 billion and $1.1 billion as of December 31, 2023 and 2022, respectively, of which $205 million and $191 million was outstanding as of December 31, 2023 and 2022, respectively.
5. Guarantees, Commitments and Contingencies
The Parent Company is the guarantor for operating leases of certain subsidiaries. All consolidated legal, regulatory and arbitration proceedings, including class actions of Ameriprise Financial are potential or current obligations of the Parent Company. The Parent Company has committed revolving credit agreements with its subsidiaries as the lender aggregating $363 million and $361 million as of December 31, 2023 and 2022, respectively, of which $246 million and nil was outstanding as of December 31, 2023 and 2022, respectively.
The Parent Company and Ameriprise Certificate Company (“ACC”) entered into a Capital Support Agreement on March 2, 2009, pursuant to which the Parent Company agrees to commit such capital to ACC as is necessary to satisfy applicable minimum capital requirements. Effective April 30, 2014, this agreement was amended to revise the maximum commitment to $50 million. For the years ended December 31, 2023, 2022 and 2021, ACC did not draw upon the Capital Support Agreement and had met all applicable capital requirements.
AFS entered into a Financial Industry Regulatory Authority (“FINRA”) approved subordinated loan agreement with the Parent Company on December 15, 2014 for regulatory net capital purposes. The agreement consists of a $200 million secured demand note. The note is secured by cash and securities equal to the principal value of the note pledged by the Parent Company. As of both December 31, 2023 and 2022, AFS had not made a demand of the principal amount.
Ameriprise Enterprise Investment Services, Inc. (“AEIS”) entered into a FINRA approved subordinated loan agreement with the Parent Company on January 25, 2017 for regulatory net capital purposes. Under this agreement, AEIS borrowed $60 million from the Parent Company with an initial term of five years to be repaid no later than January 25, 2022. Both companies have the option to renew the agreement in one year-increments in perpetuity. The agreement was renewed in January 2022 and each year thereafter, extending the current maturity date to January 25, 2025.
6. Subsequent Events
On January 30, 2024, the Parent Company contributed cash of $15 million to Ameriprise Advisor Capital, LLC. On February 14, 2024, the Parent Company received a cash dividend of $60 million from AMPF Holding, LLC. These actions were declared subsequent to the balance sheet date.